All In Biotech

Drug Trial Radar · NCT00680238

Pregnancy/Implantation Rates Using a Day 3 Score Versus Graduated Embryo Score Plus a Biochemical Marker (sHLA-G)

Pregnancy and Implantation Rates When Embryos Are Selected Based on a Single Day 3 Score (Day 3)vs Graduated Embryo Score(GES) Plus Soluble Human Leukocyte Antigen-G Expression.

Last checked: Nov 20, 2026Latest source record: May 20, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 214 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

214

Actual

Start

Jun 2004

Primary completion

Jun 2007

Study completion Jun 2007

Sponsor

Lead sponsor
University of StellenboschAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 20, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Who can join
Female only, from 25 years, up to 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Objective: To compare pregnancy rates and implantation rates when embryos are selected based on a single Day 3 (D.3) score vs. a GES score plus sHLA-G expression.

Conditions

  • Infertility

Interventions

  • Human derived FSHDrug

    Customized for each patient

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pregnancy and implantation ratesTime frame: 12 weeks

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.